Best Drug-Free Migraine Treatments for Acute Relief in 2026

Migraine is a neurological disease that can involve head pain, nausea, sensitivity to light or sound, visual symptoms, and difficulty functioning. Acute migraine treatment focuses on reducing pain and other symptoms after an attack begins. Although medication remains an important part of migraine care, some people explore drug-free acute treatments because of medication side effects, contraindications, interactions, incomplete response, concerns about medication overuse, or a preference for non-pharmaceutical options.

Drug-free acute migraine treatment is not one single technology. The options most directly designed for use during an active attack are non-invasive neuromodulation devices that stimulate specific nerves or neurological pathways. These devices differ in stimulation method, placement, treatment duration, eligible age groups, prescription requirements, portability, and ongoing cost. Behavioral therapies and acupuncture may also play a role in broader migraine care, but they are generally better categorized as preventive or complementary approaches rather than on-demand treatments for immediate acute relief.

Key Takeaways

• Cefaly is the only medical device on this list available without a prescription in the United States, Canada, and EU countries
• Cefaly combines a 60-minute Acute program and a 20-minute daily Prevent program in one forehead-worn e-TNS device
• Nerivio, gammaCore, Relivion MG, and SAVI Dual require prescriptions in the United States
• Neuromodulation devices use different pathways, including the trigeminal nerve, remote electrical neuromodulation, the vagus nerve, combined trigeminal and occipital stimulation, and single-pulse magnetic stimulation
• Behavioral migraine therapies such as cognitive behavioral therapy, biofeedback, and relaxation training are recognized non-drug treatment approaches, primarily for prevention and long-term management
• Acupuncture is a non-pharmaceutical treatment performed by a trained practitioner and is generally discussed as a preventive or complementary option rather than a rapid acute intervention

1) Cefaly

Best For: Adults seeking one prescription-free device for both acute migraine treatment and daily prevention

Access: Available without a prescription in the United States, with availability and regulatory requirements varying by region

Treatment Format: Forehead-worn external trigeminal nerve stimulation with a 60-minute Acute program and a 20-minute daily Prevent program

Cefaly is an FDA-cleared, non-invasive external trigeminal nerve stimulation device for the acute treatment of migraine with or without aura and the preventive treatment of episodic migraine in adults aged 18 or older. An adhesive electrode sits between and just above the eyebrows, allowing the device to stimulate the supraorbital and supratrochlear branches of the trigeminal nerve.

Cefaly is the most accessible medical device in this list because it does not require a U.S. prescription. It also combines acute and preventive treatment in the same reusable system rather than limiting the user to one treatment purpose.

Key Features

• FDA-cleared acute and preventive migraine treatment
• Prescription-free access in the United States, Canada, and EU countries
• Targets the trigeminal nerve through the forehead
• 60-minute Acute program
• 20-minute daily Prevent program
• Cefaly Connected model with optional app-based tracking
• Standard and hypoallergenic electrode options
• Free one-on-one coaching support in supported regions
• HSA and FSA eligibility information available through Cefaly

Cefaly-Specific Clinical Evidence

Cefaly’s clinical research includes sham-controlled studies of both acute and preventive treatment. In the ACME study, 79% of patients experienced a significant reduction in headache pain after one hour of Cefaly Acute treatment. In the PREMICE study, 38.1% of patients in the active-treatment group achieved at least a 50% reduction in monthly migraine days after three months.

These results support Cefaly as an evidence-based drug-free option compared with sham treatment. They do not establish that every person will respond or that Cefaly is clinically superior to every other migraine treatment.

Why It Made the List

Cefaly takes the first position because it offers a particularly complete combination of U.S., Canada, and EU prescription-free access; acute relief, daily prevention, non-invasive forehead placement, connected tracking features, and Cefaly-specific clinical evidence. Among the medical devices included here, it has the lowest access barrier because eligible U.S. adults can purchase it without first obtaining a prescription.

Cefaly also offers a 90-day return policy for qualifying direct purchases and a three-year limited warranty. These policies relate to return and warranty eligibility rather than guaranteed clinical results.

2) Nerivio

Best For: People who prefer a prescription, app-controlled wearable placed on the upper arm for acute and preventive migraine treatment

Access: Prescription required in the United States, with telehealth and clinician-prescribing pathways available

Treatment Format: Upper-arm wearable using remote electrical neuromodulation for treatment at migraine onset or every other day for prevention

Nerivio is a prescription, non-invasive, drug-free remote electrical neuromodulation wearable indicated for acute and preventive treatment of migraine with or without aura in people aged 8 or older. The device is worn on the upper arm and controlled through a smartphone application.

Rather than stimulating nerves at the head or neck, Nerivio applies electrical stimulation at the arm to activate conditioned pain modulation pathways. Its placement may appeal to people who prefer not to wear a device on the forehead, scalp, or neck.

Key Features

• Prescription-use migraine device
• FDA-cleared for ages 8 and older
• Acute and preventive treatment indications
• Upper-arm placement
• Smartphone-controlled sessions
• Remote electrical neuromodulation mechanism
• Home-based, self-administered format
• Replacement device or refill model may create recurring costs

Why It Made the List

Nerivio belongs on the list because it offers a distinct arm-worn approach to migraine neuromodulation and includes both acute and preventive indications. It may be relevant to people comparing device placement, pediatric eligibility, app control, and prescription-based access.

3) gammaCore

Best For: People seeking a prescription handheld device that stimulates the vagus nerve at the side of the neck

Access: Prescription required in the United States

Treatment Format: Repeated handheld stimulation applied to the neck for acute and preventive migraine treatment according to the prescribed protocol

gammaCore is a prescription, rechargeable, handheld, drug-free, non-invasive vagus nerve stimulation device. Current U.S. indications include acute and preventive migraine treatment in adolescents aged 12 or older and adults, along with several additional headache indications.

The device is placed against the side of the neck rather than attached to the forehead, scalp, or arm. Treatment involves short stimulation applications performed according to the product instructions and the prescribed treatment plan.

Key Features

• Prescription-use handheld device
• Non-invasive cervical vagus nerve stimulation
• Acute and preventive migraine indications
• Cleared for adolescents aged 12 or older and adults
• No forehead electrode or head-worn component
• Rechargeable format
• Additional FDA-cleared headache indications beyond migraine
• Treatment access and device activation managed through a prescribing pathway

Why It Made the List

GammaCore provides a different peripheral nerve target from trigeminal, occipital, arm-based, or magnetic stimulation devices. It is relevant for people comparing a compact handheld format with head-worn or adhesive-electrode systems.

4) Relivion

Best For: Adults seeking a prescription head-worn device specifically cleared for the acute treatment of migraine

Access: Prescription required in the United States, with provider and telehealth access pathways

Treatment Format: Headset-style neuromodulation that stimulates trigeminal and occipital nerve regions during an active migraine attack

Relivion MG is an FDA-cleared, prescription, drug-free neuromodulation device indicated for the acute treatment of migraine with or without aura in adults aged 18 or older. It uses a headset-style design that applies stimulation across trigeminal and occipital nerve regions.

Relivion MG differs from dual-purpose devices because its current U.S. indication is for acute treatment rather than both acute and preventive migraine therapies. The system also includes digital support and coaching components.

Key Features

• Prescription-use medical device
• Acute migraine indication for adults aged 18 or older
• Headset-style wearable design
• Simultaneous trigeminal and occipital nerve-region stimulation
• Home-based treatment format
• Digital tools and coaching support
• No current U.S. preventive migraine indication
• Requires review of device-specific contraindications and safety information

Why It Made the List

Relivion MG offers a distinctive multi-channel approach that stimulates two nerve regions associated with migraine. It provides another head-worn option for adults comparing acute-only prescription devices with systems that also include prevention.

5) SAVI Dual

Best For: Adolescents and adults seeking a prescription device that uses magnetic rather than electrical stimulation for acute and preventive migraine treatment

Access: Prescription required, with SAVI Dual currently offered through a recurring prescription program

Treatment Format: A handheld device positioned at the back of the head to deliver brief single magnetic pulses

SAVI Dual is an FDA-cleared, prescription, drug-free single-pulse transcranial magnetic stimulation device indicated for acute and preventive migraine treatment in people aged 12 or older. The device is held at the back of the head and delivers brief magnetic pulses rather than electrical stimulation through an adhesive electrode.

SAVI Dual is a central neuromodulation option, meaning it applies stimulation through the scalp toward cortical pathways rather than targeting a peripheral nerve at the forehead, neck, or arm. It is available through a prescription model, and insurance coverage may vary.

Key Features

• Prescription-use migraine device
• Acute and preventive treatment indications
• FDA-cleared for ages 12 and older
• Single-pulse transcranial magnetic stimulation
• Handheld placement at the back of the head
• No adhesive skin electrode
• Built-in treatment and diary features
• Recurring prescription or activation model

Why It Made the List

SAVI Dual represents the main magnetic-stimulation option in this comparison. Its non-electrical mechanism and back-of-head placement distinguish it from nerve-stimulation wearables, although its prescription and recurring-access model create a different experience from Cefaly’s direct-purchase, prescription-free format.

6) Behavioral Migraine Therapy

Best For: People seeking a structured, non-pharmaceutical treatment focused on migraine prevention, coping skills, and reduced migraine-related disability

Access: Licensed psychologists, behavioral health clinicians, headache programs, and selected digital or telehealth programs

Treatment Format: Structured cognitive behavioral therapy, biofeedback, relaxation training, mindfulness-based strategies, or related behavioral interventions delivered over multiple sessions

Behavioral migraine treatment is a drug-free therapeutic category that includes cognitive behavioral therapy, biofeedback, and relaxation training. These approaches focus on changing physiological and behavioral responses associated with stress, pain, and migraine-related disability.

The American Headache Society describes behavioral therapies as treatment options used alongside acute or preventive strategies to help reduce migraine frequency and intensity. They are generally framed as preventive and long-term management treatments rather than rapid methods for stopping an established attack.

Key Features

• Drug-free and non-invasive
• Includes cognitive behavioral therapy, biofeedback, and relaxation training
• Focuses on prevention, coping, function, and migraine-related disability
• Delivered through structured sessions rather than a wearable device
• May be available through in-person, telehealth, or selected digital programs
• Requires active participation over time

Why It Made the List

Behavioral migraine therapy belongs on the list because it is an established, evidence-based non-pharmaceutical treatment category rather than a general lifestyle suggestion. It offers a structured option for people comparing device-based neuromodulation with clinician-guided treatment that focuses on prevention and migraine self-management skills.

7) Acupuncture for Migraine

Best For: People interested in a practitioner-delivered, non-pharmaceutical treatment that is generally used for migraine prevention or complementary management

Access: Licensed or appropriately credentialed acupuncture practitioners, with access and professional requirements varying by location

Treatment Format: Repeated in-person sessions involving the placement of fine needles at selected points on the body

Acupuncture is a drug-free treatment used by some people as part of a migraine management plan. It is distinct from at-home comfort measures because it is a structured practitioner-delivered intervention with a defined treatment process.

Acupuncture is generally discussed as a preventive or complementary treatment rather than a guaranteed source of immediate acute relief. Research findings and individual responses vary, and practitioner qualifications, treatment schedules, cost, and coverage differ by location.

Key Features

• Drug-free treatment delivered by a trained practitioner
• Does not use electrical stimulation, magnetic pulses, or medication
• Usually provided across a series of scheduled sessions
• Most often discussed in the context of prevention or complementary care
• Availability and professional licensing requirements vary by region
• Individual treatment response can vary

Why It Made the List

Acupuncture makes the list because it is a recognized non-pharmaceutical treatment used specifically in migraine care, not simply a general wellness habit. It broadens the comparison beyond medical devices and behavioral therapies while remaining clearly distinct from hydration, meal timing, dark rooms, or other supportive strategies that are not standalone treatments.

How the Drug-Free Migraine Treatments Differ

The five medical devices in this guide do not stimulate the same pathway:

• Cefaly: External trigeminal nerve stimulation through a forehead electrode
• Nerivio: Remote electrical neuromodulation through an upper-arm wearable
• gammaCore: Non-invasive vagus nerve stimulation at the side of the neck
• Relivion MG: Combined stimulation across trigeminal and occipital nerve regions
• SAVI Dual: Single-pulse transcranial magnetic stimulation at the back of the head

They also differ in access. Cefaly is available without a U.S., Canada, and EU prescription, while Nerivio, gammaCore, Relivion MG, and SAVI Dual use prescription-based pathways. Cefaly, Nerivio, gammaCore, and SAVI Dual include both acute and preventive indications, while Relivion MG is currently cleared for acute migraine treatment. Behavioral migraine therapy and acupuncture are non-device treatments that generally involve repeated sessions and are more often used for prevention or longer-term management than immediate acute relief.

Why Cefaly Stands Out in the Comparison

Cefaly’s main distinction is not an unsupported claim that it must work better for every person. Its advantage is the combination of characteristics it brings together:

• Prescription-free U.S., Canada, and the EU access
• Acute and preventive treatment in one device
• A reusable system rather than a prescription activation or limited-use wearable model
• Direct stimulation of the trigeminal nerve, a major migraine pain pathway
• Cefaly-specific sham-controlled evidence for acute and preventive treatment
• Optional app connectivity and migraine tracking
• Direct-purchase return and warranty programs
• Coaching and customer-support resources in supported regions

For eligible adults who prioritize prescription-free access and want one device for both active attacks and daily prevention, Cefaly offers the most complete feature combination among the options reviewed here. Treatment response remains individual, and Cefaly does not cure migraines.

Safety and Medical Context

Drug-free does not mean free of contraindications, warnings, or side effects. Each neuromodulation device has product-specific restrictions involving factors such as implanted devices, metal in or near the treatment area, cardiac or neurological conditions, skin sensitivity, recent trauma, age, pregnancy, and other medical considerations.

A healthcare professional can help place device-based treatment within a broader migraine plan, especially when symptoms are new, sudden, unusual, or changing, or when medications and medical devices are being considered together.

Frequently Asked Questions

Which drug-free migraine device is available without a prescription?

Cefaly is available without a prescription in the United States, Canada, and EU countries for adults aged 18 or older within its cleared indications. Nerivio, gammaCore, Relivion MG, and SAVI Dual require prescriptions in the United States. Access rules and product availability can differ by country. Current regional product information provides the most reliable access details.

Which drug-free migraine devices provide both acute and preventive treatment?

Cefaly, Nerivio, gammaCore, and SAVI Dual include acute and preventive migraine indications. Relivion MG is currently indicated for acute migraine treatment in adults. The devices use different stimulation targets and treatment formats. Their prescribing instructions also define different schedules and eligibility requirements.

How is Cefaly different from other migraine neuromodulation devices?

Cefaly uses external trigeminal nerve stimulation through an electrode placed on the forehead. It combines 60-minute Acute treatment and 20-minute daily Prevent treatment in one reusable device. It is also the only medical device in this comparison available without a U.S. prescription. These practical differences do not guarantee that every individual will respond in the same way.

Is behavioral therapy a drug-free migraine treatment?

Yes. Cognitive behavioral therapy, biofeedback, and relaxation training are recognized behavioral migraine treatments. They are generally used to support prevention, reduce migraine-related disability, and improve coping rather than to provide immediate relief from an established attack. Treatment is usually delivered through structured sessions with a qualified clinician or validated program. The specific format and availability vary.

Is acupuncture considered a drug-free migraine treatment?

Yes. Acupuncture is a non-pharmaceutical, practitioner-delivered treatment used by some people for migraine prevention or complementary management. It is not equivalent to an FDA-cleared neuromodulation device, and it is not generally positioned as guaranteed immediate acute relief. Treatment schedules, practitioner qualifications, cost, and coverage vary. Individual responses also differ.

Does drug-free mean that a migraine device has no side effects?

No. Drug-free devices avoid taking a pharmaceutical medication, but they still have possible side effects, contraindications, warnings, and usage limits. Safety considerations differ by device mechanism and placement. The manufacturer’s current instructions for use provide the complete product-specific information.

Does Cefaly cure migraines?

No. Cefaly is intended for acute and preventive migraine treatment within its cleared indications. Clinical studies report group-level outcomes, but individual results vary. Migraine remains a neurological disease that may require ongoing evaluation and a broader management plan.